Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val R Adams

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|June 16, 2004
The effect of DB-67, a lipophilic camptothecin derivative, on topoisomerase I levels in non-small-cell lung cancer cellsAimee K Bence, Cynthia A Mattingly, Thomas G Burke, et al.
Anti-Cancer Drugs|May 2, 2002
The antiproliferative and immunotoxic effects of L-canavanine and L-canalineAimee K Bence, David R Worthen, Val R Adams, et al.
Journal of the American Heart Association|September 6, 2017
Vena Cava Filter Retrieval Rates and Factors Associated With Retrieval in a Large US CohortJoshua D Brown, Driss Raissi, Qiong Han, et al.
Journal of the American Heart Association|March 9, 2018
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant TreatmentJoshua D Brown, Amie J Goodin, Gregory Y H Lip, et al.
Journal of Oncology Practice|September 3, 2010
Description of current practices of empiric chemotherapy dose adjustment in obese adult patientsLisa A Thompson, Amber P Lawson, Stephanie D Sutphin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 30, 2008
Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimizationXiaowei Dong, Cynthia A Mattingly, Michael Tseng, et al.
Thrombosis Research|August 20, 2017
Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort studySherif M El-Refai, Esther P Black, Val R Adams, et al.
Chembiochem : a European Journal of Chemical Biology|December 11, 2008
Inactivation of the ketoreductase gilU gene of the gilvocarcin biosynthetic gene cluster yields new analogues with partly improved biological activityTao Liu, Madan K Kharel, Lili Zhu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 13, 2017
Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropeniaAllison R Butts, Christina Carracedo Bachmeier, Emily V Dressler, et al.
Cancer Research|April 23, 2009
Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATPXiaowei Dong, Cynthia A Mattingly, Michael T Tseng, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|June 16, 2004
The effect of DB-67, a lipophilic camptothecin derivative, on topoisomerase I levels in non-small-cell lung cancer cellsAimee K Bence, Cynthia A Mattingly, Thomas G Burke, et al.
Anti-Cancer Drugs|May 2, 2002
The antiproliferative and immunotoxic effects of L-canavanine and L-canalineAimee K Bence, David R Worthen, Val R Adams, et al.
Journal of the American Heart Association|September 6, 2017
Vena Cava Filter Retrieval Rates and Factors Associated With Retrieval in a Large US CohortJoshua D Brown, Driss Raissi, Qiong Han, et al.
Journal of the American Heart Association|March 9, 2018
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant TreatmentJoshua D Brown, Amie J Goodin, Gregory Y H Lip, et al.
Journal of Oncology Practice|September 3, 2010
Description of current practices of empiric chemotherapy dose adjustment in obese adult patientsLisa A Thompson, Amber P Lawson, Stephanie D Sutphin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 30, 2008
Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimizationXiaowei Dong, Cynthia A Mattingly, Michael Tseng, et al.
Thrombosis Research|August 20, 2017
Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort studySherif M El-Refai, Esther P Black, Val R Adams, et al.
Chembiochem : a European Journal of Chemical Biology|December 11, 2008
Inactivation of the ketoreductase gilU gene of the gilvocarcin biosynthetic gene cluster yields new analogues with partly improved biological activityTao Liu, Madan K Kharel, Lili Zhu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 13, 2017
Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropeniaAllison R Butts, Christina Carracedo Bachmeier, Emily V Dressler, et al.
Cancer Research|April 23, 2009
Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATPXiaowei Dong, Cynthia A Mattingly, Michael T Tseng, et al.
Pageof 4